Finance News – Bristol Myers
What is your interest today?
Bitcoin
Crypto
Btc
Stocks
Ceo
Tariffs
Shares
Investors
Stock
Stock Market
Crypto Assets
Cryptocurrency
Ethereum
Price
Markets
Bse
Xrp
Etf
Stablecoin
Investment
Blockchain
Ipo
Eth
Index
Solana
Sec
Trade
Earnings
Inflation
Interest Rates
Token
Revenue
Sensex
Coinbase
Wall Street
Treasury
Nse
Nasdaq
China
Bse Sensex
Traders
Federal Reserve
Nifty
Gold
Sp 500
Tesla
Investor
Profit
Economy
Company
Public Investment Fund
Usi
Imc Trading
Car Insurers
Ibstock
Trident Digital Tech Holdings
Reputational Risk
Primary Offerings
Oracle Voters
Bbf
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
CNBC Business • Jul 01, 2025
Our bottom 5 stocks for the first half of 2025 — and why we still own them
Despite underperforming in early 2025, these stocks remain in the portfolio due to their potential for long-term value appreciation and anticipated improvements in market condition...
Read Full Article →
CNBC Business • Jun 02, 2025
Bristol Myers' new cancer partnership is promising, but doesn't change our stance on the stock yet
Bristol Myers’ collaboration in advanced cancer therapies highlights potential growth opportunities, yet investors remain cautious as the company’s long-term financial impact and m...
Read Full Article →
CNBC Business • May 29, 2025
Why the stock rally fizzled — plus, our latest thinking on Goldman and Bristol Myers
The recent market surge lost momentum, impacting investor confidence and prompting updated analyses on key firms like Goldman Sachs and Bristol Myers within the Investing Club’s ti...
Read Full Article →